• Molbio Diagnostics Private Limited

  • Year of Investment

    2020

  • Sector

    Life Sciences

  • Status

    Current

  • Visit Website

    www.molbiodiagnostics.com

Description:

Molbio, a Goa based Company along with its subsidiary Bigtec labs has developed and commercialized TruenatTM, the world’s first commercial Point-of-Care (PoC) molecular diagnostics platform using PCR (polymerase chain reaction) technology. TruenatTM can diagnose 22 infectious diseases (like TB, H1N1, Dengue, HIV, Hepatitis etc.) and has a pipeline of additional 43 diseases (such as Coronavirus, MERS, etc.). This indigenous technology was approved by ICMR in 2018, after 3 years of validation study across various sites in India. Established in 2000, Molbio and Bigtec have spent 18 years on R&D, collaborated with reputed institutions in India and across the globe to develop and deploy molecular diagnostics in resource limited settings. The TruenatTM assay is rapid (results within 60 minutes) and affordable. The equipment is battery operated and can be used in peripheral centers without extensive infrastructure. At present, TruenatTM devices are installed in over 500+ private labs and 350+ primary health centers in India and across the world in 27 countries.